Home › NDC Lookup › Ingredients › Coal Tar › 00096-0737-08
DHS TAR coal .005 g/g Shampoo, 250.08 g — NDC 00096-0737-08 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

DHS TAR coal .005 g/g Shampoo, 250.08 g — NDC 0096-0737-08 (Billing 00096-0737-08)

by Person and Covey · 250.08 g in 1 BOTTLE

This is a package of 250.08 g of DHS TAR coal .005 g/g Shampoo from Person and Covey, marketed since Jun 1995 and currently FDA-listed; retail pharmacies pay about $0.0411 per mL (NADAC). It is the main listing for this product, which comes in 2 package sizes.

NDC 00096-0737-08
🏷️ FDA NDC (as labeled) 0096-0737-08 billing pads the labeler segment with a zero
This package
Contains250.08 g Cost per mL$0.0411 NADAC Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.8771/unit — full pricing hub ↓
Main listing for product 0096-0737 · Also comes in: 125.04 g 0096-0737-04
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

NDC database record

One package, one record: these facts belong to NDC 0096-0737-08 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
0096 labeler · 0737 product · 08 package
Package marketed since
Jun 1, 1996
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0300960737047
Medicaid fills, this package
37 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0096-0737-08
Product NDC 0096-0737
11-digit billing NDC 00096073708
NCPDP billing unit ML — per mL (volume)
RxCUI 210490, 309381
UNII R533ESO2EC
UPC 0300960737047
Application # M032
SPL Set ID 4d088ad5-1f89-48fe-ac8a-12cb62847b38
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1995-06-01
Route TOPICAL
Dosage form SHAMPOO
Substance COAL TAR

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90520010004505
GPI class DHS Tar
GCN Seq No 005977
GCN 23611
HICL code 002557
Ingredient (HICL) Coal Tar
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L6
Therapeutic class — intermediate (HIC2) Irritants
HIC3 code L6A
Therapeutic class — specific (HIC3) Irritants/Counter-Irritants
AHFS code 84:32.00.00
AHFS class Keratoplastic Agents
FDB label name DHS TAR 0.5% SHAMPOO
FDB brand name Dhs Tar
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 005977
  • GCN: 23611
  • GPI-14 (Medi-Span): 90520010004505
  • HICL (First Databank): 002557
  • AHFS class code: 84:32.00.00
  • RxCUI (RxNorm): 210490
Why two NDCs? The FDA registers this code as 0096-0737-08 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00096-0737-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name DHS TAR 0.5% SHAMPOO Ingredient Coal Tar
📗 Our plain-language guide HelloPharmacist
  • It relieves the itching, scaling, flaking and redness of psoriasis, seborrheic dermatitis and dandruff. Which of these a product treats depends on the brand, so check your package....
  • It depends on the product. Most coal tar shampoos say to use them at least twice a week, leaving the lather on for several minutes. Some ointments, gels and lotions can be used one...
  • Be careful. Coal tar can make you more likely to sunburn for up to 24 hours after you apply it. Cover up and limit sun exposure during that time.
  • Don't combine it with light therapy or prescription psoriasis medicines unless your doctor says it's okay. Check with me or your doctor first if you're not sure.
📖 Read our full Coal Tar guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly $0.041 —
Medicaid paysCMS SDUD · 12 mo $0.8771 —
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per mL) — tap or hover for the price & month
Jun 2026 Aug 2026 Sep 2026 $0.045 $0.041
▼ Down 8% over the last 3 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
00096-0737-04 0096-0737-04 125.04 g in 1 BOTTLE — — 1995-06-01 — Active
00096-0737-08 You're viewing this Main listing 250.08 g in 1 BOTTLE $0.0411 / mL — 1996-06-01 — Active

Pack size FAQ

What quantity is in this package?
This package contains 250.08 g — 250.08 g in 1 bottle.
How does this package differ from NDC 00096-0737-04?
Both are DHS TAR coal .005 g/g Shampoo — the drug itself is identical. This page's package is the 250.08 g one, while NDC 00096-0737-04 is the 125.04 g package.
What NDC number is used to bill for this package of DHS TAR coal .005 g/g Shampoo?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Thera-Gel 5 mg/mL 00904-5259-44 Major 251 ml $0.009 — Availability likely save 79%
DHS tar gel .005 g/g 00096-0736-08 Person 249.6 g $0.041 — Availability likely —
Dhs Tar .005 g/gthis 00096-0737-08 Person 250.08 g $0.041 — Availability likely —
DHS Tar 5 mg/mL 00096-0813-08 Person 240 ml — — FDA listed —
Walgreens Original T-Gel Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 5 mg/mL 00363-1591-01 Walgreen 1 bottle — — FDA listed —
Meijer T Plus Gel Coal Tar Anti-Dandruff 5 mg/mL 41250-0249-01 Meijer 251 ml — — FDA listed —
Medicasp Anti-Dandruff 5 mg/mL 50066-0040-06 Genomma 1 bottle — — FDA listed —
therapeutic tar anti-dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 5 mg/mL 50804-0887-01 GOODSENSE 473 ml — — FDA listed —
Family Wellness Therapeutic Tplus PLUS Dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 5 mg/mL 55319-0485-01 FAMILY 251 ml — — FDA listed —
True plus Real Therapeutic T plus Plus Original Strength Tar Dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 5 mg/mL 67385-0702-01 Garcoa, 1 bottle — — FDA listed —
amazon basics therapeutic tar anti-dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 5 mg/mL 72288-0043-01 AMAZON.COM 473 ml — — FDA listed —
QC Anti Dandruff T Plus 5 mg/mL 75376-0286-08 Guangzhou 236 ml — — FDA listed —
TopCare Therapeutic Anti-Dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 5 mg/mL 76162-0190-01 Topco 251 ml — — FDA listed —
meijer therapeutic t plus plus tar gel dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 5 mg/mL 79481-0083-01 Meijer 473 ml — — FDA listed —
Equate Therapeutic Dandruff Original Strength Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 5 mg/mL 79903-0087-01 Wal-Mart 1 bottle — — FDA listed —
Equate Therapeutic Dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis 5 mg/mL 79903-0291-01 Wal-Mart 1 bottle — — FDA listed —
QC Anti Dandruff T Plus 5 mg/mL 83324-0286-08 Chain 236 ml — — FDA listed —
Pete and Pedro Control Anti Itch Dandruff 62.5 mg/mL 84503-0508-00 PETE 236 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1995
On the market since
Jun 1995
📍
2026
Currently FDA-listed
31 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Coal Tar inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII XF417D3PSL
    Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
  • UNII 62V75NI93W
    A surfactant derived from coconut oil that helps cleanse and remove oils from skin or hair. In medicines and personal care products, it acts as a cleanser and foaming agent.
  • UNII 7JNC8VN07M
    A synthetic compound made from polyethylene glycol combined with stearic acid. It acts as an emulsifier and surfactant to help mix oil and water-based ingredients and improve how the medicine spreads or dissolves.
  • UNII 451W47IQ8X
    Sodium chloride is common table salt. It's used in medicines as a buffer to maintain proper pH, as a filler to add bulk, or to adjust the osmotic balance in liquid formulations.
  • UNII E8458C1KAA
    A synthetic detergent and cleansing agent derived from lauric acid. It helps break down oils and improve how active ingredients mix into the formula, and may also serve as a foaming or emulsifying agent in topical preparations.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

6 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesPurified Water Triethanolamine Lauryl Sulfate Cocamidopropyl Hydroxysultaine PEG 8 Distearate Sodium Chloride Hydroxypropyl Methylcellulose Lemon fruit oil Citric Acid

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerPerson and Covey
FDA applicationM032 (OTC MONOGRAPH DRUG)
Labeler code00096
First marketedJun 1995
Product typeHuman Otc Drug
Portfolio23 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 18 words ▾

Indications and Use Helps prevent recurrence of scalp itching and flaking associated with Psoriasis, Seborrheic Dermatitis and Dandruff.

⏱️ Dosage and Administration 46 words ▾

Dosage and Administration Wet hair thoroughly, apply a liberal amount of shampoo and massage into lather. Allow lather to remain on scalp for several minutes. Rinse hair well and repeat application. For best results use at least twice a week or as directed by a physician.

⚠️ Warnings 134 words ▾

WARNINGS For external use only. Ask a physician before use if you have Psoriasis or Seborrheic Dermatitis that covers a large area of the body. Do not get into eyes.

If contact occurs, rinse eyes thoroughly with water. Use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn for up to 24 hours after application.

Do not use for prolonged periods without consulting a physician. Do not use this product with other forms of Psoriasis therapy such as ultraviolet radiation or prescription drugs, unless directed to do so by a physician. In rare instances, discoloration of gray, blond tinted or bleached hair may occur.

Stop use and ask physician if condition worsens or does not improve after regular use. Store away from excessive heat or cold.

🧪 Active Ingredient 4 words ▾

Active Ingredient Coal Tar

🧪 Inactive Ingredients 21 words ▾

Inactive Ingredients Purified Water Triethanolamine Lauryl Sulfate Cocamidopropyl Hydroxysultaine PEG 8 Distearate Sodium Chloride Hydroxypropyl Methylcellulose Lemon fruit oil Citric Acid

🎯 Purpose 9 words ▾

Purpose Controls symptoms of Psoriasis, Seborrheic Dermatitis and Dandruff.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of the Reach of Children Yes. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 20 words ▾

PACKAGE LABEL.PRINCIPAL DISPLAY dhs tar shampoo 4 oz.jpg image description

PACKAGE LABEL.PRINCIPAL DISPLAY dhs tar shampoo 8 oz.jpg image description

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
37
Units reimbursed last 4 qtrs
8.5K
Gross reimbursed last 4 qtrs
$7.5K
Avg / prescription
$201.97
Avg / unit
$0.8771
Latest quarter Q1 2026
13Rx
Medicaid pays / mL
$0.8771
gross reimbursed
vs
NADAC / mL
$0.0411
acquisition cost
=
Spread
+$0.8360
+2034% vs cost
What Medicaid paid per mL (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
100% FFS
Fee-for-service · 37 Rx Managed care · 0 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 8,520 units · 149 per 100k residents MN Wisconsin: no data reported WI Michigan: no data reported MI New York: no data reported NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: no data reported OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: no data reported CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: no data reported KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
149149
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Minnesota 149 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
125.04 g00096-0737-04 No Medicaid data
Drug total (last 4 qtrs): 37 Rx · 8,520 units · $7,473 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for DHS TAR (this brand).

Top reported reactions

Psoriasis420
Malaise300
Fatigue267
Pain252
Nasopharyngitis236
Skin Exfoliation227
Fall223

Age at onset

Child1
Adult62
Elderly66

Reporter sex

760 reports
Male · 36%
Female · 64%

Serious outcomes

Disabling132
Death13
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 115 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.